When research and development costs are rising speedily pharmaceutical companies are looking for ways to cut down costs on the same. Also there is an urgent need also to shortening developmental cycle times by a good percentage.



It is believed that pharmaceutical companies will spend a good share of budget on the research and development as it will give them some edge in the international export markets. Chinese firms equipped with domestic favorable environment are already occupying some niche verticals in Europe and America. In this scenario, pharmaceutical spend on outsourcing is believed to be reaching double-digit growth in the next three to five years.



Sniffing some good business opportunities in the segment Research and Markets has announced Outsourcing Clinical Development service.



Read